Moxie Self-Management and Education Support Program
NCT07280325 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9000
Last updated 2026-05-11
Summary
Health education and self-management support are key facilitators of health behaviours. Moxie is a mixed media, self-management, education and support program for Albertans living with cardiovascular-related chronic conditions. Moxie is built upon our previous work within the ACCESS study (2015-21, n=4761), a RCT that previously tested the Moxie intervention in Alberta. Results demonstrated that MOXIE reduced the rate of hospitalizations (notably for hypertension, angina, hyper/hypoglycemia, heart failure decompensation, and acute kidney complications) by 34% in a population of low-income seniors living with cardiovascular-related chronic conditions.
However, before Moxie can be effectively implemented province-wide, another trial is necessary to determine whether benefits can be observed in a larger cohort of patients with cardiovascular-related chronic conditions recruited immediately after hospital discharge (n=9000). Furthermore, the effectiveness of the two components of the ACCESS trial intervention will be assessed individually:
(a) The Moxie Program, a tailored health and disease education component developed by a user-experience-centric design process incorporating patients, behavioural scientists, disease specialists, health system administrators and marketing/advertising professionals; and (b) the facilitated relay of clinical information to healthcare providers (letters).
The trial is designed as a 2x2 factorial pragmatic, individual-level randomized pragmatic trial of these different interventions. This would yield the following groups:
1. Moxie SMES Program
2. Facilitated Relay
3. Moxie SMES Program and Facilitated Relay
4. True control
Self-management education and support (SMES) intervention: This includes weekly physical mailers sent directly to patients' homes throughout the study containing information about chronic conditions, medication use, diet, physical activity, smoking cessation, and self-management/wellness principles. These messages will be refined by the social impact creative design partner and reviewed by clinicians and patients to ensure clinical safety and appropriate tone. Weekly mailers will encourage participants to enroll and consent to participate in the digital program by scanning a QR code or accessing a website where they will sign up for their own personalized Moxie mobile health app, complete a digital consent form and opt-in for electronic delivery of Moxie messages.
Facilitated relay intervention: Participants allocated to this intervention will receive letters by mail, one addressed to them, one to their primary care provider, and one to their pharmacist. The letters will not be sent to their primary care provider directly; rather, they will be sent to patients who will be encouraged to take them to their primary care provider and pharmacist should they decide to do so. We hope this will empower patients to start discussions with their healthcare providers. This also supports patient autonomy by enabling patients to decide whether they want to take them to their provider or not. If for whatever reason they do not feel that this is going to be beneficial or of interest, they are not required to do so. The letter would contain a note to the patient's healthcare provider stating that their patient is at-risk of cardiovascular disease and that evidence has shown that the pharmacotherapy is effective in improving outcomes for patients similar to the participant.
The primary outcome is readmission for cardiovascular-specific ambulatory care-sensitive conditions (ACSC) based on the most responsible diagnosis listed in CIHI Discharge Abstract Database-(DAD), using established algorithms within 12 months from randomization. This outcome includes all repeat admissions in the study period as recorded in the health record. This outcome is a count variable. We will calculate and compare each intervention arm's mean number and distribution of hospitalizations.
Conditions
- Chronic Kidney Disease
- Diabetes (DM)
- Heart Disease
- Stroke
- Chronic Disease
Interventions
- BEHAVIORAL
-
Moxie SMES Letters
Weekly mailer for the Moxie SMES Program.
- BEHAVIORAL
-
Facilitated Relay Letter
One-time Facilitated Relay letter for the participant to share with their healthcare provider.
Sponsors & Collaborators
-
Emergence Creative
collaborator UNKNOWN -
University of Calgary
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 40 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-01
- Primary Completion
- 2028-05-01
- Completion
- 2029-12-31
More Related Trials
-
Secondary Cardiovascular Prevention Post-acute Myocardial Infarction (AMI) Through a Web-based Empowerment Program
NCT05782023 ·Status: UNKNOWN ·Phase: NA
-
Chronic Remote Ischemic Conditioning to Modify Post-MI Remodeling
NCT01817114 ·Status: UNKNOWN ·Phase: NA
-
Prehospital Evaluation and Economic Analysis of Different Coronary Syndrome Treatment Strategies - PREDICT
NCT00747656 ·Status: COMPLETED
-
Sonothrombolysis in Patients With STEMI
NCT03092089 ·Status: COMPLETED ·Phase: PHASE2
-
Coronary Thromboaspiration and Infarct Size
NCT00456066 ·Status: TERMINATED ·Phase: NA
-
Wiser Choices in Acute Myocardial Infarction
NCT00888537 ·Status: COMPLETED ·Phase: NA
-
Multicenter Cohort of STEMI Patients
NCT03070496 ·Status: COMPLETED ·Phase: NA
-
TIMELY: a Patient-centred Lifestyle Program for Patients With Coronary Artery Disease
NCT05955625 ·Status: COMPLETED ·Phase: NA
-
RETRIEVE-AMI Study
NCT05307965 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Care Process and the Quality of STEMI Care
NCT02961777 ·Status: COMPLETED
-
Safety And Feasibility of Early DischargE - a Prospective And Randomized Trial of Low-risk Primary Percutaneous Coronary Intervention (PCI) Patients
NCT00474214 ·Status: COMPLETED ·Phase: NA
-
HMO Research Network CERT: Acute Myocardial Infarction
NCT00211172 ·Status: COMPLETED ·Phase: NA
-
Effect of an Adult EDUcation Program on CArdiovascular ouTcomEs in Post-myocardial-infarction Patients
NCT04007887 ·Status: UNKNOWN ·Phase: NA
-
The RECOVERY Study: Using Supersaturated Oxygen Therapy To Treat Small Vessel Blockages After a Heart Attack
NCT07000266 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Field Implementation of the autoRIC Device in STEMI
NCT03265067 ·Status: COMPLETED ·Phase: NA
-
A Smartphone APPlication for the Transmission of ECGs in the Management of Patients Presenting With Suspected Heart Attacks in the Hamilton, Niagara, Haldimand, and Brant Area
NCT05290389 ·Status: COMPLETED
-
Clinical Outcomes of Angioplasty Postconditioning
NCT00419198 ·Status: COMPLETED ·Phase: NA
-
Adherence to Prescribed Medication: Elucidating the Gap Between Guideline Recommendation and Real Life in Myocardial Infarction
NCT03661710 ·Status: UNKNOWN
-
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
NCT04957719 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Randomised EValuation of Therapies for microvAscuLar Injury in STEACS
NCT06935383 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Nitric Oxide in Myocardial Infarction Size
NCT00568061 ·Status: TERMINATED ·Phase: PHASE2
-
Myocardial Infarction Triage and Intervention Project (MITI)
NCT00000468 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Montelukast on STEMl Patients
NCT07320625 ·Status: RECRUITING ·Phase: PHASE3
-
Doxycycline to Protect Heart Muscle After Heart Attacks
NCT03508232 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
NCT00007657 ·Status: COMPLETED ·Phase: PHASE3